1. Home
  2. VANI vs ADVB Comparison

VANI vs ADVB Comparison

Compare VANI & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

HOLD

Current Price

$1.23

Market Cap

95.8M

Sector

Health Care

ML Signal

HOLD

ADVB

Advanced Biomed Inc.

HOLD

Current Price

$4.23

Market Cap

109.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VANI
ADVB
Founded
1998
2014
Country
United States
United States
Employees
N/A
31
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
95.8M
109.2M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
VANI
ADVB
Price
$1.23
$4.23
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
321.7K
129.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
14.00
N/A
EPS
N/A
N/A
Revenue
$4,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.26
Revenue Growth
N/A
N/A
52 Week Low
$0.91
$0.19
52 Week High
$1.92
$5.69

Technical Indicators

Market Signals
Indicator
VANI
ADVB
Relative Strength Index (RSI) 43.34 88.92
Support Level $1.17 $0.41
Resistance Level $1.24 N/A
Average True Range (ATR) 0.06 0.36
MACD -0.00 0.41
Stochastic Oscillator 38.89 70.43

Price Performance

Historical Comparison
VANI
ADVB

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: